Cargando…
Heparin-induced bullous hemorrhagic dermatosis()
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121283/ https://www.ncbi.nlm.nih.gov/pubmed/35606191 http://dx.doi.org/10.1016/j.therap.2022.02.007 |
_version_ | 1784711123129335808 |
---|---|
author | Hamdi, Douja Korbi, Mouna Sahnoun, Dhouha Boussaada, Mohamed Mehdi El Mabrouk, Randa Said Belhadjali, Hichem Chaabane, Amel Zili, Jameleddine |
author_facet | Hamdi, Douja Korbi, Mouna Sahnoun, Dhouha Boussaada, Mohamed Mehdi El Mabrouk, Randa Said Belhadjali, Hichem Chaabane, Amel Zili, Jameleddine |
author_sort | Hamdi, Douja |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9121283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91212832022-05-20 Heparin-induced bullous hemorrhagic dermatosis() Hamdi, Douja Korbi, Mouna Sahnoun, Dhouha Boussaada, Mohamed Mehdi El Mabrouk, Randa Said Belhadjali, Hichem Chaabane, Amel Zili, Jameleddine Therapie Letter to Editor Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2022 2022-03-10 /pmc/articles/PMC9121283/ /pubmed/35606191 http://dx.doi.org/10.1016/j.therap.2022.02.007 Text en © 2022 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to Editor Hamdi, Douja Korbi, Mouna Sahnoun, Dhouha Boussaada, Mohamed Mehdi El Mabrouk, Randa Said Belhadjali, Hichem Chaabane, Amel Zili, Jameleddine Heparin-induced bullous hemorrhagic dermatosis() |
title | Heparin-induced bullous hemorrhagic dermatosis() |
title_full | Heparin-induced bullous hemorrhagic dermatosis() |
title_fullStr | Heparin-induced bullous hemorrhagic dermatosis() |
title_full_unstemmed | Heparin-induced bullous hemorrhagic dermatosis() |
title_short | Heparin-induced bullous hemorrhagic dermatosis() |
title_sort | heparin-induced bullous hemorrhagic dermatosis() |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121283/ https://www.ncbi.nlm.nih.gov/pubmed/35606191 http://dx.doi.org/10.1016/j.therap.2022.02.007 |
work_keys_str_mv | AT hamdidouja heparininducedbulloushemorrhagicdermatosis AT korbimouna heparininducedbulloushemorrhagicdermatosis AT sahnoundhouha heparininducedbulloushemorrhagicdermatosis AT boussaadamohamedmehdi heparininducedbulloushemorrhagicdermatosis AT elmabroukrandasaid heparininducedbulloushemorrhagicdermatosis AT belhadjalihichem heparininducedbulloushemorrhagicdermatosis AT chaabaneamel heparininducedbulloushemorrhagicdermatosis AT zilijameleddine heparininducedbulloushemorrhagicdermatosis |